CYTOLYTIC EFFECTS OF COMPLEMENT CLEAVAGE PRODUCT, C3A

被引：35

作者：

FERLUGA, J ^{[1
]}

SCHORLEMMER, HU ^{[1
]}

BAPTISTA, LC ^{[1
]}

ALLISON, AC ^{[1
]}

机构：

[1] CLIN RES CTR,DIV CELL PATHOL,HARROW HA1 3UJ,MIDDLESEX,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1976年 / 34卷 / 06期

关键词：

D O I：

10.1038/bjc.1976.223

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：626 / 634

页数：9

共 34 条

[1] ISOLATION OF MURINE SARCOMA VIRUS-TRANSFORMED MOUSE CELLS WHICH ARE NEGATIVE FOR LEUKEMIA VIRUS FROM AGAR SUSPENSION CULTURES [J].

BASSIN, RH ;

TUTTLE, N ;

FISCHINGER, PJ .

INTERNATIONAL JOURNAL OF CANCER, 1970, 6 (01) :95-+

[2]

Bitter-Suermann D, 1970, Immunochemistry, V7, P955, DOI 10.1016/0019-2791(70)90002-9

[3]

BITTERSUERMANN D, 1972, IMMUNOLOGY, V23, P267

[4] ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J].

BOKISCH, VA ;

MULLEREB.HJ .

JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) :2427-&

[5] ISOLATION OF A FRAGMENT (C3A) OF THIRD COMPONENT OF HUMAN COMPLEMENT CONTAINING ANAPHYLATOXIN AND CHEMOTACTIC ACTIVITY AND DESCRIPTION OF AN ANAPHYLATOXIN INACTIVATOR OF HUMAN SERUM [J].

BOKISCH, VA ;

MULLEREB.HJ ;

COCHRANE, CG .

JOURNAL OF EXPERIMENTAL MEDICINE, 1969, 129 (05) :1109-&

[6]

BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P51

[7]

BRUNNER KT, 1970, IMMUNOLOGY, V18, P499

[8] IS PRIMARY COMPLEMENT LESION INSUFFICIENT FOR LYSIS - FAILURE OF CELLS DAMAGED UNDER OSMOTIC PROTECTION TO LYSE IN EDTA OR AT LOW-TEMPERATURE AFTER REMOVAL OF OSMOTIC PROTECTION [J].

BURAKOFF, SJ ;

MARTZ, E ;

BENACERRAF, B .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1975, 4 (01) :108-126

[9]

Cerottini J C, 1974, Adv Immunol, V18, P67, DOI 10.1016/S0065-2776(08)60308-9

[10]

CHANG RSM, 1954, P SOC EXP BIOL MED, V87, P440

← 1 2 3 4 →